Pegylated interferon therapy of chronic hepatitis D: In need of revision

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|61|4|1109-1111

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.61, Iss.4, 2015-04, pp. : 1109-1111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized study comparing vitamin D3 and 1α‐Hydroxyvitamin D3 in combination with pegylated interferon/ribavirin therapy for chronic hepatitis C

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 9, 2015-09 ,pp. : 1384-1390

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence of Depression in Patients with Chronic Hepatitis C Receiving Combination Therapy of Pegylated Interferon-Alpha and Ribavirin

By  

Psychotherapy and Psychosomatics, Vol. 83, Iss. 5, 2014-08 ,pp. : 308-309

Karger

Access to resources Recommend Favorite

Pegylated Interferon plus Ribavirin Combination Therapy for Chronic Hepatitis C in Patients with Congenital Coagulation Disorders

By  

Acta Haematologica, Vol. 120, Iss. 2, 2008-10 ,pp. : 63-69

Karger

Access to resources Recommend Favorite

The serum IL‐23 level predicts the response to pegylated interferon therapy in patients with chronic hepatitis B

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 5, 2015-05 ,pp. : 1549-1556

John Wiley & Sons Inc

Access to resources Recommend Favorite

The royal wedding in chronic hepatitis B: The haves and the have‐nots for the combination of pegylated interferon and nucleos(t)ide therapy

By  

HEPATOLOGY, Vol. 61, Iss. 5, 2015-05 ,pp. : 1459-1461

John Wiley & Sons Inc

Access to resources Recommend Favorite